Cervical-Cancer Screening with Human Papillomavirus and Cytologic CotestingSCHIFFMAN, Mark; SOLOMON, Diane.The New England journal of medicine. 2013, Vol 369, Num 24, pp 2324-2331, issn 0028-4793, 8 p.Article

Cervical cancer and human papillomavirus in indigenous Guyanese womenKIGHTLINGER, Rebecca S; IRVIN, William P; ARCHER, Kellie J et al.American journal of obstetrics and gynecology. 2010, Vol 202, Num 6, pp 626-628, issn 0002-9378, 3 p.Conference Paper

Cervical Cancers After Human Papillomavirus VaccinationBELLER, Uziel; ABU-RUSTUM, Nadeem R.Obstetrics and gynecology (New York. 1953). 2009, Vol 113, Num 2, pp 550-552, issn 0029-7844, 3 p., 2Article

Imagerie des cancers de l'utérus : CANCERS DE L'UTÉRUS = Imaging of uterine carcinomas : UTERINE CANCERSTHOMASSIN-NAGGARA, Isabelle; DECHOUX, Sophie; BALLESTER, Marcos et al.La Revue du praticien (Paris). 2014, Vol 64, Num 6, pp 798-801, issn 0035-2640, 4 p.Article

p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapyATTIAS-GEVA, Zohar; BENTOV, Itay; KIDRON, Dvora et al.European journal of cancer (1990). 2012, Vol 48, Num 10, pp 1570-1580, issn 0959-8049, 11 p.Article

Uterine Serous Papillary Carcinomas Overexpress Human Trophoblast-Cell-Surface Marker (Trop-2) and Are Highly Sensitive to Immunotherapy With hRS7, a Humanized Anti-Trop-2 Monoclonal AntibodyVARUGHESE, Joyce; COCCO, Emiliano; BELLONE, Stefania et al.Cancer. 2011, Vol 117, Num 14, pp 3163-3172, issn 0008-543X, 10 p.Article

Distribution of platinum in the female genital tract and efficacy of radiotherapy combined with transcatheter arterial infusion of cisplatin for locally advanced stage IIIb carcinoma of the uterine cervixNAGAI, Nobutaka; KANEYASU, Yasuko; KOMATSU, Masaaki et al.Oncology reports. 2009, Vol 21, Num 3, pp 585-591, issn 1021-335X, 7 p.Article

Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapyBELLONE, S; ROQUE, D; SCHWARTZ, P. E et al.British journal of cancer. 2012, Vol 106, Num 9, pp 1543-1550, issn 0007-0920, 8 p.Article

Histological Grade Predicts for Recurrence in Patients with Uterine Endometrioid Carcinoma without Myometrial InvolvementZAKI, Mark A; ROBINS, Jared R; FATTEH, Saif et al.Anticancer research. 2012, Vol 32, Num 9, pp 4061-4065, issn 0250-7005, 5 p.Article

Trends in the Utilization of Adjuvant Vaginal Cuff Brachytherapy and/or External Beam Radiation Treatment in Stage I and II Endometrial Cancer: A Surveillance, Epidemiology, and End-Results StudyPATEL, Mehul K; COTE, Michele L; ALI-FEHMI, Rouba et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 1, pp 178-184, issn 0360-3016, 7 p.Article

Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumabTODESCHINI, P; COCCO, E; RATNER, E et al.British journal of cancer. 2011, Vol 105, Num 8, pp 1176-1182, issn 0007-0920, 7 p.Article

hl-con I, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinomaCOCCO, E; HU, Z; SCHWARTZ, P. E et al.British journal of cancer. 2010, Vol 103, Num 6, pp 812-819, issn 0007-0920, 8 p.Article

Human papillomavirus and cervical cancerSCHIFFMAN, Mark; CASTLE, Philip E; JERONIMO, Jose et al.Lancet (British edition). 2007, Vol 370, Num 9590, pp 890-907, issn 0140-6736, 18 p.Article

IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesisBAEGE, Astrid C; DISBROW, Gary L; SCHLEGEL, Richard et al.Journal of virology. 2004, Vol 78, Num 11, pp 5720-5727, issn 0022-538X, 8 p.Article

Cervical Cancer Prevention Through Human Papillomavirus Vaccination: Using the Teachable Moment for Educational InterventionsCARLOS, Ruth C; DEMPSEY, Amanda F; PATEL, Divya A et al.Obstetrics and gynecology (New York. 1953). 2010, Vol 115, Num 4, pp 834-838, issn 0029-7844, 5 p.Article

Cervical Cancer Screening With Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone: What Screening Intervals Are Physicians Recommending?SARAIYA, Mona; BERKOWITZ, Zahava; YABROFF, K. Robin et al.Archives of internal medicine (1960). 2010, Vol 170, Num 11, pp 977-985, issn 0003-9926, 9 p.Article

Cervical human papillomavirus detection is not affected by menstrual phaseTOTA, Joseph E; RAMANAKUMAR, Agnihotram V; MAHMUD, Salaheddin M et al.Sexually transmitted infections. 2013, Vol 89, Num 3, pp 202-206, issn 1368-4973, 5 p.Article

Papillary Syncytial Metaplasia Associated With Endometrial Breakdown Exhibits an Immunophenotype That Overlaps With Uterine Serous CarcinomaMCCLUGGAGE, W. Glenn; MCBRIDE, Hilary A.International journal of gynecological pathology. 2012, Vol 31, Num 3, pp 206-210, issn 0277-1691, 5 p.Article

Ampulla of Vater metastasis from recurrent uterine cervix carcinoma presenting as groove pancreatitisTAE HOON LEE; PARK, Sang-Heum; CHANG KYUN LEE et al.Gastrointestinal endoscopy (Print). 2011, Vol 73, Num 2, issn 0016-5107, p. 362Article

Molecular markers of endometrial carcinoma detected in uterine aspiratesCOLAS, Eva; PEREZ, Cristina; RIGAU, Marina et al.International journal of cancer (Print). 2011, Vol 129, Num 10, pp 2435-2444, issn 0020-7136, 10 p.Article

Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid CarcinomaBIN GUAN; MAO, Tsui-Lien; PANUGANTI, Pradeep K et al.The American journal of surgical pathology. 2011, Vol 35, Num 5, pp 625-632, issn 0147-5185, 8 p.Article

Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomasROMANI, Chiara; COMPER, Fabrizio; BANDIERA, Elisabetta et al.American journal of obstetrics and gynecology. 2009, Vol 201, Num 1, pp 70-72, issn 0002-9378, 3 p.Article

Platinum/Taxane-based Chemotherapy With or Without Radiation Therapy Favorably Impacts Survival Outcomes in Stage I Uterine Papillary Serous CarcinomaNICKLES FADER, Amanda; DRAKE, Richard D; O'MALLEY, David M et al.Cancer. 2009, Vol 115, Num 10, pp 2119-2127, issn 0008-543X, 9 p.Article

Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas: Immunohistochemical Analysis of 201 CasesYEMELYANOVA, Anna; HONGXIU JI; SHIH, Ie-Ming et al.The American journal of surgical pathology. 2009, Vol 33, Num 10, pp 1504-1514, issn 0147-5185, 11 p.Article

Carcinoma of the Lower Uterine Segment : A Newly Described Association With Lynch SyndromeWESTIN, Shannon N; LACOUR, Robin A; URBAUER, Diana L et al.Journal of clinical oncology. 2008, Vol 26, Num 36, pp 5965-5971, issn 0732-183X, 7 p.Article